Neurologist | Neurology - Clinical Neurophysiology

Dr. Charles Ogunro, M.D.

145 Hospital Ave, Suite 211, Du Bois, Pennsylvania, 15801-1462

About Dr. Charles Ogunro

Dr. Charles Ogunro is a neurologist based in Du Bois, Pennsylvania who is specialized in Clinical Neurophysiology. Active license number of Dr. Charles Ogunro is MD036291L for Clinical Neurophysiology in Pennsylvania. His current practice location is 145 Hospital Ave, Suite 211, Du Bois. Patients can reach him at 814-375-2070 or can fax him at 814-375-2076. Dr. Charles Ogunro is M.D. in Clinical Neurophysiology and his NPI number (Unique professional ID assigned by NPPES) is 1710058730.

Dr. Charles Ogunro is subspecialized with psychiatric or neurologic expertise in the diagnosis and management of central, peripheral, and autonomic nervous system disorders using combined clinical evaluation and electrophysiologic testing such as electroencephalography (EEG), electromyography (EMG), and nerve conduction studies (NCS).

Practice Information

Dr. Charles Ogunro speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Dr. Charles Ogunro
Specialization Clinical Neurophysiology
Credentials M.D.
Gender Male
Practice Address: 145 Hospital Ave, Suite 211
Du Bois, PA - 15801-1462
Fax 814-375-2076

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1710058730
NPI Enumeration Date: 13 Nov, 2006
NPI Last Update On: 20 Sep, 2016

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Charles Ogunro are as mentioned below.

License NumberSpecializationStateStatus
MD036291LClinical Neurophysiology PennsylvaniaPrimary
95-118Clinical Neurophysiology New MexicoSecondary
49598Clinical Neurophysiology KentuckySecondary
TP318Clinical Neurophysiology KentuckySecondary

Other Medical Identifiers

Other legacy medical identifiers associated with Dr. Charles Ogunro such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
00237590MedicaidNew York
7100413180MedicaidKentucky
0010358330005MedicaidPennsylvania

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Dr. Charles Ogunro
145 Hospital Ave, Suite 211
Du Bois, PA - 15801-1462
Phone: 814-375-2070
Fax: 814-375-2076

Book an Appointment with Dr. Charles Ogunro

To schedule an appointment, contact Dr. Charles Ogunro at 145 Hospital Ave, Suite 211, Du Bois, Pennsylvania or call on below stated phone number.

Call to Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Dr. Charles Ogunro:

Dr. Charles Ogunro is a neurologist specializing in Clinical Neurophysiology. He is subspecialized with psychiatric or neurologic expertise in the diagnosis and management of central, peripheral, and autonomic nervous system disorders using combined clinical evaluation and electrophysiologic testing such as electroencephalography (EEG), electromyography (EMG), and nerve conduction studies (NCS).

Yes, Dr. Charles Ogunro is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.

Dr. Charles Ogunro practices at 145 Hospital Ave, Suite 211, Du Bois, Pennsylvania, 15801-1462.

To schedule an appointment with Dr. Charles Ogunro, please contact the office at 814-375-2070.

Reviews & Feedback

Have you visited Dr. Charles Ogunro? Share your experience to help others looking for neurologist in Du Bois, PA.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.